Literature DB >> 16175083

Abnormalities of the RB1 pathway in ovarian serous papillary carcinoma as determined by overexpression of the p16(INK4A) protein.

Jane E Armes1, Rohan Lourie, Melanie de Silva, Georgia Stamaratis, Alison Boyd, Beena Kumar, Gareth Price, Simon Hyde, David Allen, Peter Grant, Deon J Venter.   

Abstract

Dysfunction of proteins involved in the G1 to S transition of the cell cycle, such as p16(INK4A) and RB1, is common in many cancer types. A screen of p16 protein expression was performed in benign, borderline, and invasive ovarian tumors, together with endometrial cancers, aligned on a tissue microarray. We observed frequent p16 overexpression in serous papillary carcinomas of ovarian and endometrial origin. An extended cohort of ovarian serous papillary carcinomas was examined to further evaluate the frequency of p16 overexpression. Strong, uniform staining in the majority of cancer cells occurred commonly in invasive serous papillary ovarian cancers, particularly in grade 3 carcinomas. RB1 protein expression abnormalities were rare. Our data indicate that abnormalities in the retinoblastoma pathway, as determined by p16 overexpression, are common in serous papillary carcinomas and are probably an early event.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16175083     DOI: 10.1097/01.pgp.0000172083.94934.1e

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  7 in total

Review 1.  Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems.

Authors:  Russell Vang; Ie-Ming Shih; Robert J Kurman
Journal:  Adv Anat Pathol       Date:  2009-09       Impact factor: 3.875

2.  Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence.

Authors:  Po Zhao; Xin Mao; Ian C Talbot
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

3.  Comparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical study of 130 ovarian carcinomas.

Authors:  Donna Catherine Ferguson; Daniel Jerad Long; Megan Christine Smith; Laura Deeanne Craig-Owens; Julie Means; Oluwole Fadare; Mohamed Mokhtar Desouki
Journal:  J Ovarian Res       Date:  2015-06-05       Impact factor: 4.234

4.  Stromal p16 expression is significantly increased in endometrial carcinoma.

Authors:  Gun Yoon; Chang Won Koh; Nara Yoon; Ji-Ye Kim; Hyun-Soo Kim
Journal:  Oncotarget       Date:  2017-01-17

5.  An Emerging Anti-p16 Antibody-BC42 Clone as an Alternative to the Current E6H4 for Use in the Female Genital Tract Pathological Diagnosis: Our Experience and a Review on p16ink4a Functional Significance, Role in Daily-Practice Diagnosis, Prognostic Potential, and Technical Pitfalls.

Authors:  Giuseppe Angelico; Angela Santoro; Frediano Inzani; Patrizia Straccia; Saveria Spadola; Damiano Arciuolo; Michele Valente; Nicoletta D'Alessandris; Roberta Benvenuto; Antonio Travaglino; Antonio Raffone; Gian Franco Zannoni
Journal:  Diagnostics (Basel)       Date:  2021-04-16

6.  Stromal p16 expression is significantly increased in malignant ovarian neoplasms.

Authors:  Nara Yoon; Gun Yoon; Cheol Keun Park; Hyun-Soo Kim
Journal:  Oncotarget       Date:  2016-10-04

7.  Immunohistochemical Characterization Improves the Reproducibility of the Histological Diagnosis of Ovarian Carcinoma

Authors:  Nabiha Missaoui; Said Salhi; Ahlem Bdioui; Sarra Mestiri; Nihed Abdessayed; Moncef Mokni; Mohamed Tahar Yacoubi
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.